Pro Chart

Labcorp Inc.

NYSE: LH · Real-Time Price · USD
323.48
+1.06 (0.33%)
At close: Aug 12, 2026, 3:59 PM

Labcorp Inc. (LH) Stock Price, Analysis & Data

0.33%
Bid315.33
Market Cap26.23B
Revenue (ttm)14.35B
Net Income (ttm)1B
Beta0.84
EPS (ttm)12.09
PE Ratio (ttm)26.67
Forward PE16.35
P/B (ttm)3.04
P/S (ttm)1.83
Earnings DateNov 3, 2026
Ask326
Volume291,991
Avg. Volume (20D)667,135
Open316.13
Previous Close322.42
Day's Range315.33 - 323.63
52-Week Range244.52 - 323.97
AnalystBuy
Price Target350 (8.20%)
Dividends$2.88 (0.89%)
Ex-Dividend DateAug 28, 2026

About LH

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialt...

Sector Healthcare
IPO Date Mar 29, 1990
Employees 71,000
Stock Exchange NYSE
Ticker Symbol LH
Full Company Profile

Financial Performance

In 2025, Labcorp's revenue was 13.95B, an increase of 7.25% compared to the previous year's 13.01B. Earnings were 876.5M, an increase of 17.49%.

Financial Statements

Analyst Forecast

According to 16 analyst ratings, the average rating for LH stock is "Buy". The 12-month stock price forecast is 350, which is upside of 8.2% from the latest price.

Stock Forecasts

Earnings Surprise

Labcorp has released their quarterly earnings on Jul 30, 2026:
  • Revenue of $3.73B misses estimates by $0, with 5.78% YoY growth.
  • EPS of 4.99 exceeds estimates by 0.22, with 14.71% YoY growth.
  • Labcorp Inc. is scheduled to release its earnings on Nov 3, 2026, before market opens.
    Analysts project revenue of ... Upgrade